The goal of this project is to create DNA nanoparticles that specifically bind to Chronic Lymphocytic Leukemia (CLL) cells, which could then be used for diagnostic testing, in vivo targeting, and drug delivery. Our research group has developed a technology that utilizes rolling circle amplification (RCA) of circular oligonucleotide templates containing random nucleotides to produce libraries of single-stranded DNA, with each particle in the library containing hundreds of copies of its template, and each library containing over 10 billion unique particles. We have already had success generating nanoparticles against human dendritic cells, the mouse pancreatic cell line, Panc-02, and the human breast cancer cell line, MDA-MB- 231, and we have recently selected our first particles that bind CLL.
In Aim 1, we will optimize the size of our particles for use in vivo and assess their biodistribution. In im 2, we will obtain blood samples from CLL patients and perform selections, counter-selections, and mock-selections, followed by high-throughput sequencing to determine the hierarchy of particles in the selection process.
In Aim 3, we will utilize two xenograft models for CLL to perform additional selections in vivo, as this method will allow for selection of particles that function and target well in the body. We will use particles selected in this project to detect minimal residual disease in patient samples and we will test drug- loaded specific particles for effectiveness in mice.

Public Health Relevance

The goal of this project is to develop a new type of therapeutic delivery vehicle for leukemia that is made of DNA and can specifically grab on to cancer cells while avoiding healthy cells. When attached to drugs, these DNA particles can potentially kill cancer cells while preventing toxic side effects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA180499-02
Application #
8895065
Study Section
Special Emphasis Panel (ZRG1-F09B-P (20))
Program Officer
Jakowlew, Sonia B
Project Start
2014-07-04
Project End
2017-07-03
Budget Start
2015-07-04
Budget End
2016-07-03
Support Year
2
Fiscal Year
2015
Total Cost
$56,042
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Ruff, Laura E; Sapre, Ajay A; Plaut, Justin S et al. (2016) Selection of DNA nanoparticles with preferential binding to aggregated protein target. Nucleic Acids Res 44:e96